PMVP (STOCKS)
PMV Pharmaceuticals, Inc
$1.060000
-0.050000 (-4.50%)
Prev close: $1.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David H. Mack
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $56.53M
- Employees
- 47
- P/E (TTM)
- -0.72
- P/B (TTM)
- 0.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.34 | $-0.42 | +0.0782 | +18.70% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.41 | +0.0731 | +17.70% |
|
Sep 2025 (Q3)
|
$-0.40 | $-0.41 | +0.0106 | +2.58% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.39 | -0.0190 | -4.86% |
Financial Statements
| Revenues | $5.38M |
| Benefits Costs and Expenses | $83.70M |
| Costs And Expenses | $83.70M |
| Operating Expenses | $83.66M |
| Research and Development | $67.77M |
| Other Operating Expenses | $15.90M |
| Operating Income/Loss | -$83.66M |
| Income/Loss From Continuing Operations After Tax | -$78.34M |
| Income/Loss From Continuing Operations Before Tax | -$78.32M |
| Interest Income/Expense After Provision For Losses | $5.38M |
| Interest Income/Expense Operating, Net | $5.38M |
| Net Income/Loss | -$78.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$78.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$78.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.49 |
| Diluted Earnings Per Share | -$1.49 |
| Basic Average Shares | 158,554,921 |
| Diluted Average Shares | 158,554,921 |
| Assets | $96.56M |
| Current Assets | $95.78M |
| Cash | $93.55M |
| Other Current Assets | $2.23M |
| Noncurrent Assets | $782.00K |
| Fixed Assets | $203.00K |
| Other Non-current Assets | $579.00K |
| Liabilities | $8.60M |
| Current Liabilities | $8.60M |
| Accounts Payable | $1.63M |
| Other Current Liabilities | $6.96M |
| Noncurrent Liabilities | $0.00 |
| Equity | $87.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $87.97M |
| Liabilities And Equity | $96.56M |
| Net Cash Flow From Operating Activities | -$74.99M |
| Net Cash Flow From Operating Activities, Continuing | -$74.99M |
| Net Cash Flow From Investing Activities | $62.28M |
| Net Cash Flow From Investing Activities, Continuing | $62.28M |
| Net Cash Flow From Financing Activities | -$650.00K |
| Net Cash Flow From Financing Activities, Continuing | -$650.00K |
| Net Cash Flow | -$13.36M |
| Net Cash Flow, Continuing | -$13.36M |
| Comprehensive Income/Loss | -$78.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$78.44M |
| Other Comprehensive Income/Loss | -$99.00K |